The U.S. Patent and Trademark Office and U.S. Food and Drug Administration will be discussing the intricacies that biotech and medtech independent inventors and startups face when securing intellectual property (IP) rights from the USPTO and when seeking regulatory approval from the FDA. The online program will be held on September 8, 2022 from 10:00 am to 2:00 pm (PT). Topics to be covered during the webinar will include:
• Navigating USPTO patent and FDA regulatory processes with an emphasis on biotech and medtech industries
• Initiatives, strategies, tips, and best practices to protect your discoveries and innovations
Those interested in registering for the webinar can do so here.
Comments